市场调查报告书
商品编码
1494788
2030 年精细化学品市场预测:按产品、材料、功能、应用、最终用户和地区分類的全球分析Fine Chemicals Market Forecasts to 2030 - Global Analysis By Product, Material, Functionality, Application, End User and By Geography |
根据Stratistics MRC的数据,2024年全球精细化学品市场规模为1,514.1亿美元,预计将以9.2%的复合年增长率成长,到2030年将达到2,567.5亿美元。
精细化学品是针对特定应用而生产的相对少量的高纯度化学品。这些化学品经过精确的合成和精製过程,以满足严格的品质标准。这些化学物质的特点是成分精确、纯度高(通常超过 99%)。它们的特征是分子结构复杂,用于精确的化学和物理特性,而不是大量使用。
美国国家卫生统计中心公布的美国治疗药物使用资料显示,2020年,透过医生就诊订购和提供的药品以及透过医院急诊就诊给药的药品约29亿种。
日益关注特种化学品
特种化学品具有独特的性能和用途,需要精确的配方和高度纯化的原料,通常属于精细化学品的范畴。随着製药、电子和农业化学品等行业对特定应用的专用化学品的需求不断增加,对精细化学品的需求也不断增加。这一趋势正在推动精细化工产业的创新、投资和扩张,推动整体市场成长并提升其在各个工业领域的重要性。
复杂的合成过程
精细化学品需要复杂的合成工艺,这主要是由于製药和特种化学品等行业对纯度和品质的严格要求。此类过程通常涉及复杂的化学反应、反应条件的精确控制以及多个精製步骤以实现所需的纯度和功能。然而,这些工艺的复杂性增加了製造成本和上市时间,阻碍了市场成长。
契约製造的成长
合约开发和受託製造厂商(CDMO) 代表製药、生物技术和特种化学品公司提供专业知识和设备来製造精细化学品。这种外包趋势使客户能够专注于自己的核心能力,同时利用 CDMO 功能进行高效且具成本效益的生产。对外包服务的需求不断增加,特别是在药物开发领域,直接增加了对精细化学品的需求,推动了市场的成长和扩张。
专利到期和非专利竞争
当品牌药的专利到期时,学名药以较低的价格进入市场,从而减少了对其製造中使用的精细化学品的需求。这加剧了精细化学品製造商之间的竞争,往往导致价格下降和利润率缩小。此外,学名药使用更简单的化学配方,这可能会降低所需精细化学品的复杂性和数量。因此,专利到期和非专利竞争可能会阻碍精细化学品市场的成长前景。
COVID-19 的影响
由于供应链中断、劳动力短缺以及製药和汽车等关键行业的需求减少,COVID-19 大流行最初扰乱了精细化学品市场。然而,随着製药业大力开发疫苗和治疗方法,市场也逐渐復苏。此外,卫生和健康标准意识的提高也增加了对消毒剂和个人保健产品中使用的精细化学品的需求。整体而言,疫情加速了精细化学品市场的某些领域的发展,同时也为其他领域带来了暂时的挑战。
生物基原料产业预计将在预测期内成为最大的产业
生物基原料领域预计将出现良好成长。生物基原料提供了传统石化原料的永续,并且在精细化学品的生产中变得越来越重要。这些原料源自于生物质、农业残留物和废弃物等可再生资源,为化学製造提供了环保的方法。透过利用生物基原料,精细化工产业可以减少其环境足迹,减少对石化燃料的依赖,并为更永续和循环的经济做出贡献,同时保持高品质的产品标准。
预计药物发现和开发领域在预测期内的复合年增长率最高。
预计药物发现和药物开发领域在预测期内将出现最高的复合年增长率。精细化学品透过提供药物研究必需的高品质、纯物质,在药物发现和开发中发挥重要作用。这些化学物质有多种用途,包括活性药物成分 (API) 合成、配方开发和分析测试。这些化学物质使研究人员能够创造新的化合物、优化配方并确保产品的安全性和功效。
由于製药、农业化学品和特种化学品行业的成长,预计亚太地区在预测期内将占据最大的市场占有率。推动市场成长的因素包括医疗保健支出的增加、人口的成长和工业化的扩大。此外,税收优惠和法律规范等有利的政府倡议正在吸引对精细化学品行业的投资。整体而言,在不同最终用户产业的需求和新兴市场持续开拓的推动下,亚太地区精细化学品市场有望显着成长。
在製药、农业化学品和特种化学品行业强劲需求的推动下,预计北美在预测期内将呈现最高的复合年增长率。该地区注重研究和创新,拥有先进的製造能力和严格的监管标准,确保了高品质的产品。不断增加的研发投资,加上永续性意识的不断增强,正在塑造市场格局。整体而言,北美精细化学品市场持续蓬勃发展,为各产业提供广泛的特种产品和解决方案。
According to Stratistics MRC, the Global Fine Chemicals Market is accounted for $151.41 billion in 2024 and is expected to reach $256.75 billion by 2030 growing at a CAGR of 9.2% during the forecast period. Fine chemicals are high-purity chemical substances produced in relatively small quantities for specific applications. These chemicals undergo precise synthesis and purification processes to meet stringent quality standards. They are distinguished by their exact composition and high level of purity, often exceeding 99%. They are characterized by their complex molecular structures and are utilized for their precise chemical and physical properties rather than their bulk quantities.
According to the data on therapeutic drug use in the U.S. published by National Centre for Health Statistics, the number of drugs that were ordered and provided through physician office visits reached around 2.9 billion, and the number of drugs that were given or prescribed through hospital emergency department visits reached around 336 million in 2020.
Rising focus on specialty chemicals
Specialty chemicals, characterized by unique properties and applications, require precise formulations and high-purity ingredients, often falling within the realm of fine chemicals. As industries such as pharmaceuticals, electronics, and agrochemicals increasingly demand specialty chemicals for specific purposes, the need for fine chemicals also grows. This trend fuels innovation, investment, and expansion in the fine chemicals sector, driving its overall market growth and contributing to its significance in various industrial segments.
Complex synthesis processes
Fine chemicals have complex synthesis processes primarily due to the stringent purity and quality requirements demanded by industries like pharmaceuticals and specialty chemicals. These processes often involve intricate chemical reactions, precise control of reaction conditions, and multiple purification steps to achieve the desired level of purity and functionality. However, the complexity of these processes increases production costs and time-to-market, hampering market growth.
Growth in contract manufacturing
Contract development and manufacturing organizations (CDMOs) offer specialized expertise and facilities for the production of fine chemicals on behalf of pharmaceutical, biotechnology, and specialty chemical companies. This outsourcing trend allows clients to focus on core competencies while leveraging the CDMOs' capabilities for efficient and cost-effective production. As the demand for outsourcing services increases, particularly in pharmaceutical drug development, it directly propels the demand for fine chemicals, driving market growth and expansion.
Patent expirations and generic competition
When patents for branded drugs expire, generic versions enter the market at lower prices, leading to reduced demand for fine chemicals used in their production. This intensifies competition among fine chemical manufacturers, often resulting in price erosion and shrinking profit margins. Additionally, generic drugs may utilize simpler chemical formulations, reducing the complexity and volume of fine chemicals required. As a result, patent expirations and generic competition can hinder the growth prospects of the fine chemicals market.
Covid-19 Impact
The covid-19 pandemic initially disrupted the fine chemicals market due to supply chain disruptions, labor shortages, and reduced demand from key industries like pharmaceuticals and automotive. However, the market gradually rebounded as the pharmaceutical sector surged to develop vaccines and treatments. Additionally, increased awareness of hygiene and health standards boosted demand for fine chemicals used in disinfectants and personal care products. Overall, the pandemic accelerated certain segments while posing temporary challenges to others within the fine chemicals market.
The bio-based feedstocks segment is expected to be the largest during the forecast period
The bio-based feedstocks segment is estimated to have a lucrative growth. Bio-based feedstocks are becoming increasingly important in the production of fine chemicals, offering sustainable alternatives to traditional petrochemical sources. These materials, derived from renewable sources such as biomass, agricultural residues, or waste streams, provide a greener approach to chemical manufacturing. By harnessing bio-based feedstocks, fine chemical industries can reduce their environmental footprint, decrease dependence on fossil fuels, and contribute to a more sustainable and circular economy while maintaining high-quality product standards.
The drug discovery & development segment is expected to have the highest CAGR during the forecast period
The drug discovery & development segment is anticipated to witness the highest CAGR growth during the forecast period. Fine chemicals play a crucial role in drug discovery and development by providing high-quality, pure substances essential for pharmaceutical research. These chemicals serve various purposes, including synthesis of active pharmaceutical ingredients (APIs), formulation development, and analytical testing. They enable researchers to create novel compounds, optimize drug formulations, and ensure product safety and efficacy.
Asia Pacific is projected to hold the largest market share during the forecast period due to its growing pharmaceutical, agrochemical, and specialty chemicals industries. Factors driving market growth include increasing healthcare expenditure, rising population, and expanding industrialization. Moreover, favourable government initiatives, such as tax incentives and supportive regulatory frameworks, attract investments in the fine chemicals sector. Overall, the Asia Pacific fine chemicals market is poised for substantial growth, fuelled by demand from diverse end-user industries and ongoing industrial developments.
North America is projected to have the highest CAGR over the forecast period, driven by robust demand from pharmaceutical, agrochemical, and specialty chemical sectors. With a strong emphasis on research and innovation, the region boasts advanced manufacturing capabilities and stringent regulatory standards, ensuring high-quality products. Increasing investments in R&D, coupled with growing awareness of sustainability, are shaping the market landscape. Overall, the North American fine chemicals market continues to thrive, offering a wide range of specialty products and solutions to various industries.
Key players in the market
Some of the key players profiled in the Fine Chemicals Market include BASF SE, Merck KGaA, Lonza Group, Evonik Industries AG, DSM Corporation, Johnson Matthey, Albemarle Corporation, Clariant AG, Arkema SA, Sumitomo Chemical Corporation, Pfizer Inc., Huntsman Corporation, Univar Solutions Inc., Mitsui Chemicals Inc., W. R. Grace & Co., Novasep, Denisco Corporation, TCI Chemicals, Kenko Corporation and Solvay SA.
In May 2024, BASF launched a new insecticide 'Efficon' to counter the threat posed by piercing and sucking pests causing extensive damage amounting to 35 to 40% loss in the productivity and yield of the produce to agricultural crops in India.
In June 2023, Univar Solutions Inc., a prominent global supplier of specialized chemicals and ingredients, announced a partnership with W.R. Grace & Co. This strategic collaboration involves the distribution of W.R. Grace & Co.'s renowned product, SYLOID FP silica. This specific product plays a pivotal role as a versatile ingredient in the formulation of prescription drugs, over-the-counter pharmaceutical solutions, and dietary supplements.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.